IRhythm Technologies EBITDA Margin 2015-2025 | IRTC
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for IRhythm Technologies (IRTC) over the last 10 years. The current EBITDA margin for IRhythm Technologies as of March 31, 2025 is .
| IRhythm Technologies EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.62B | $-0.08B | -13.25% |
| 2024-12-31 | $0.59B | $-0.09B | -14.86% |
| 2024-09-30 | $0.56B | $-0.13B | -22.82% |
| 2024-06-30 | $0.54B | $-0.11B | -19.89% |
| 2024-03-31 | $0.51B | $-0.11B | -20.43% |
| 2023-12-31 | $0.49B | $-0.11B | -22.11% |
| 2023-09-30 | $0.47B | $-0.09B | -18.39% |
| 2023-06-30 | $0.45B | $-0.09B | -19.03% |
| 2023-03-31 | $0.43B | $-0.09B | -21.40% |
| 2022-12-31 | $0.41B | $-0.09B | -22.87% |
| 2022-09-30 | $0.38B | $-0.11B | -28.95% |
| 2022-06-30 | $0.36B | $-0.11B | -29.92% |
| 2022-03-31 | $0.34B | $-0.10B | -30.29% |
| 2021-12-31 | $0.32B | $-0.09B | -27.33% |
| 2021-09-30 | $0.32B | $-0.07B | -21.32% |
| 2021-06-30 | $0.31B | $-0.05B | -16.67% |
| 2021-03-31 | $0.28B | $-0.05B | -19.57% |
| 2020-12-31 | $0.27B | $-0.04B | -13.91% |
| 2020-09-30 | $0.25B | $-0.05B | -19.51% |
| 2020-06-30 | $0.23B | $-0.06B | -27.07% |
| 2020-03-31 | $0.23B | $-0.05B | -22.17% |
| 2019-12-31 | $0.21B | $-0.05B | -23.83% |
| 2019-09-30 | $0.20B | $-0.04B | -20.71% |
| 2019-06-30 | $0.18B | $-0.03B | -18.78% |
| 2019-03-31 | $0.16B | $-0.04B | -23.78% |
| 2018-12-31 | $0.15B | $-0.04B | -29.25% |
| 2018-09-30 | $0.13B | $-0.04B | -30.08% |
| 2018-06-30 | $0.12B | $-0.04B | -30.00% |
| 2018-03-31 | $0.11B | $-0.03B | -28.44% |
| 2017-12-31 | $0.10B | $-0.03B | -25.25% |
| 2017-09-30 | $0.09B | $-0.02B | -21.35% |
| 2017-06-30 | $0.08B | $-0.02B | -19.75% |
| 2017-03-31 | $0.07B | $-0.01B | -17.81% |
| 2016-12-31 | $0.07B | $-0.01B | -21.54% |
| 2016-06-30 | $0.04B | $-0.01B | -34.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $4.548B | $0.592B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.456B | 59.10 |
| Doximity (DOCS) | United States | $11.587B | 53.64 |
| Hims & Hers Health (HIMS) | United States | $10.739B | 111.58 |
| Tempus AI (TEM) | United States | $10.555B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.789B | 59.21 |
| Hinge Health (HNGE) | United States | $3.638B | 0.00 |
| Privia Health (PRVA) | United States | $2.696B | 184.25 |
| Enovis (ENOV) | United States | $1.922B | 10.72 |
| Phreesia (PHR) | United States | $1.725B | 0.00 |
| 10x Genomics (TXG) | United States | $1.602B | 0.00 |
| Schrodinger (SDGR) | United States | $1.550B | 0.00 |
| Azenta (AZTA) | United States | $1.521B | 70.70 |
| Omnicell (OMCL) | United States | $1.398B | 24.66 |
| Evolent Health (EVH) | United States | $1.384B | 117.90 |
| Clover Health Investments (CLOV) | United States | $1.303B | 0.00 |
| Claritev (CTEV) | United States | $0.747B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.611B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.513B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.480B | 0.00 |
| Talkspace (TALK) | United States | $0.463B | 138.50 |
| Outset Medical (OM) | United States | $0.370B | 0.00 |
| TruBridge (TBRG) | United States | $0.343B | 761.67 |
| Health Catalyst (HCAT) | United States | $0.283B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.265B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.167B | 0.00 |
| American Well (AMWL) | United States | $0.133B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.126B | 0.00 |
| Pulmonx (LUNG) | United States | $0.112B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 3.97 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.018B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |